Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Fox, Caroline S, Matsushita, Kunihiro, Woodward, Mark, Bilo, Henk JG, Chalmers, John, Heerspink, Hiddo J Lambers, Lee, Brian J, Perkins, Robert M +9 more·2012·The Lancet
DOI 10.1016/s0140-6736(12)61350-6

Cited by (1,001)

Items 101–200 of 1,001

  1. Association between prediabetes and risk of chronic kidney disease: a systematic review and meta‐analysis
    Justin Basile Echouffo-Tcheugui, K.M. Venkat Narayan, David Weisman, Sherita Hill Golden, Bernard G. Jaar · 2016 · Diabetic Medicine
  2. Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA ‐ T2D trial
    Per‐Henrik Groop, Mark Emmanuel Cooper, Vlado Perkovic, Berthold Hocher, Keizo Kanasaki, Masakazu Haneda, Guntram Schernthaner, Kumar Sharma, Robert C. Stanton, Robert D. Toto et al. · 2017 · Diabetes Obesity and Metabolism
  3. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes
    Takashi Wada, Masakazu Haneda, Kengo Furuichi, Tetsuya Babazono, Hiroki Yokoyama, Kunitoshi Iseki, Shin‐ichi Araki, Toshiharu Ninomiya, Shigeko Hara, Yoshiki Suzuki et al. · 2013 · Clinical and Experimental Nephrology
  4. Body-mass index and risk of advanced chronic kidney disease: prospective analyses from a primary care cohort of 1.4 million adults in England
    Herrington, William G., Smith, Margaret, Bankhead, Clare, Matsushita, Kunihiro, Stevens, Sarah, Holt, Tim, Hobbs, F. D. Richard, Coresh, Josef, Woodward, Mark · 2017 · PLOS ONE
  5. Renal Hyperfiltration as a Novel Marker of All-Cause Mortality
    Minseon Park, Eunsil Yoon, Youn-Hee Lim, Ho Kim, Jinwook Choi, Hyung‐Jin Yoon · 2014 · Journal of the American Society of Nephrology
  6. Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease
    Andrew S. Levey, Morgan Erika Grams, Lesley A. Inker · 2022 · New England Journal of Medicine
  7. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
    Vlado Perkovic, Rajiv Agarwal, Paola Fioretto, Brenda R. Hemmelgarn, Adeera Levin, Merlin C. Thomas, Christoph Wanner, B.L. Kasiske, David Collins. Wheeler, Per‐Henrik Groop et al. · 2016 · Kidney International
  8. Cohort Profile: The Taiwan MJ Cohort: half a million Chinese with repeated health surveillance data
    Xifeng Wu, Shan Pou Tsai, Chwen Keng Tsao, Mu-Lin Chiu, Min Kuang Tsai, Po Jung Lu, June Han Lee, Chien Hwa Chen, Christopher Wen, Shu‐Sen Chang et al. · 2017 · International Journal of Epidemiology
  9. Effects of self-management on chronic kidney disease: A meta-analysis
    Mei-Yu Lin, Megan F. Liu, Lan-Fang Hsu, Pei-Shan Tsai · 2017 · International Journal of Nursing Studies
  10. Novel Insights into Diabetic Kidney Disease
    Ewelina Młynarska, Dominika Buławska, Witold Czarnik, Joanna Hajdys, Gabriela Majchrowicz, Filip Prusinowski, Magdalena Stabrawa, Jacek Rysz, Beata Franczyk · 2024 · International Journal of Molecular Sciences
  11. Roles and crosstalks of macrophages in diabetic nephropathy
    Hai-Di Li, Yong‐Ke You, Baoyi Shao, Weifeng Wu, Yi-Fan Wang, Jian-Bo Guo, Xiao‐Ming Meng, Haiyong Chen · 2022 · Frontiers in Immunology
  12. Incidence and risk factors for hip fractures in dialysis patients
    Milka Maravic, Agnès Ostertag, P. U. Torres, Martine Esther Cohen-Solal · 2013 · Osteoporosis International
  13. Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits
    NICOLETTE CLAIRE BISHOP, James O. Burton, Matthew P. M. Graham-Brown, David J. Stensel, João L. Viana, Emma L Watson · 2023 · Nature Reviews Nephrology
  14. Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
    Ferdinando Carlo Sasso, Pia Clara Pafundi, Vittorio Simeon, Luca De Nicola, Paolo Chiodini, Raffaele Galiero, Luca Rinaldi, Riccardo Nevola, Teresa Salvatore, Celestino Sardu et al. · 2021 · Cardiovascular Diabetology
  15. Proximal tubule mTORC1 is a central player in the pathophysiology of diabetic nephropathy and its correction by SGLT2 inhibitors
    Kogot-Levin, Aviram, Hinden, Liad, Riahi, Yael, Israeli, Tal, Tirosh, Boaz, Cerasi, Erol, Mizrachi, Ernesto Bernal, Tam, Joseph, Mosenzon, Ofri, Leibowitz, Gil · 2020 · Cell Reports
  16. JCS 2022 Guideline Focused Update on Diagnosis and Treatment in Patients With Stable Coronary Artery Disease
    Shintaro Nakano, Shun Kohsaka, Taishiro Chikamori, Kenji Fukushima, Yoshio Kobayashi, Ken Kozuma, Susumu Manabe, Hitoshi Matsuo, Masato Nakamura, Takayuki Ohno et al. · 2022 · Circulation Journal
  17. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats
    Naoki Ishiuchi, Ayumu Nakashima, Shigehiro Doi, Ken Yoshida, Satoshi Maeda, Ryo Kanai, Yumi Yamada, Takeshi Ike, Toshiki Doi, Yukio Kato et al. · 2020 · Stem Cell Research & Therapy
  18. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study
    for the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group, Giuseppe Penno, Anna Solini, Emanuela Orsi, Enzo Bonora, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Luigi Cavalot, Olga Lamacchia et al. · 2018 · Diabetologia
  19. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”
    the Italian Diabetes Society and the Italian Society of Nephrology, Giuseppe Pugliese, Giuseppe Penno, Andrea Natali, Federica Barutta, Salvatore Di Paolo, Gianpaolo Reboldi, Loreto Gesualdo, Luca De Nicola · 2019 · Journal of Nephrology
  20. Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: a review of their kidney and heart protection
    Michos, Erin D., Bakris, George L., Rodbard, Helena W., Tuttle, Katherine R. · 2023 · American Journal of Preventive Cardiology
  21. Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
    Shankar Siva, Mathias Bressel, Mark A. Sidhom, Swetha Sridharan, Ben G. L. Vanneste, Ryan Davey, Rebecca Montgomery, Jeremy Ruben, Farshad Foroudi, Braden Higgs et al. · 2024 · The Lancet Oncology
  22. Hypoglycemia in Patients with Diabetes and Renal Disease
    Mazen Alsahli, John E. Gerich · 2015 · Journal of Clinical Medicine
  23. Past Decline Versus Current eGFR and Subsequent ESRD Risk
    Csaba Pal Kovesdy, Josef Coresh, Shoshana H. Ballew, Mark Woodward, Adeera Levin, David M. J. Naimark, Joseph V. Nally, Dietrich Rothenbacher, Bénédicte Stengel, Kunitoshi Iseki et al. · 2015 · Journal of the American Society of Nephrology
  24. Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease
    The EMPA-KIDNEY Collaborative Group · 2024 · New England Journal of Medicine
  25. Incorporating kidney disease measures into cardiovascular risk prediction: Development and validation in 9 million adults from 72 datasets
    Kunihiro Matsushita, Simerjot Kaur Jassal, Yingying Sang, Shoshana H. Ballew, Morgan Erika Grams, Aditya Surapaneni, Johan Ärnlöv, Nisha Bansal, Milica Božić, Hermann Brenner et al. · 2020 · EClinicalMedicine
  26. Combination therapy for kidney disease in people with diabetes mellitus
    van Raalte, Daniël H., Bjornstad, Petter, Cherney, David Z. I., de Boer, Ian H., Fioretto, Paola, Gordin, Daniel, Persson, Frederik, Rosas, Sylvia E., Rossing, Peter, Schaub, Jennifer A. et al. · 2024 · Nature Reviews Nephrology
  27. Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes: the DCCT/EDIC study
    de Boer, Ian H., Gao, Xiaoyu, Cleary, Patricia A., Bebu, Ionut, Lachin, John M., Molitch, Mark E., Orchard, Trevor, Paterson, Andrew D., Perkins, Bruce A., Steffes, Michael W. et al. · 2016 · Clinical Journal of the American Society of Nephrology
  28. Cordyceps cicadae polysaccharides ameliorated renal interstitial fibrosis in diabetic nephropathy rats by repressing inflammation and modulating gut microbiota dysbiosis
    Junling Yang, Huibin Dong, Ya Wang, Yun Jiang, Wenna Zhang, Yongming Lu, Yan Chen, Lei Chen · 2020 · International Journal of Biological Macromolecules
  29. Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008–12 National Health Examination Survey
    Luca De Nicola, Chiara Donfrancesco, Roberto Minutolo, Cinzia Lo Noce, Luigi Palmieri, Amalia De Curtis, Licia Iacoviello, Carmine Zoccali, Loreto Gesualdo, Giuseppe Conte et al. · 2014 · Nephrology Dialysis Transplantation
  30. Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk
    Benjamin M. Scirica, Ofri Mosenzon, Deepak L. Bhatt, Jacob, A. Udell, Philippe Gabríel Steg, Darren K. McGuire, KyungAh Im, Estella Kanevsky, Christina Stahre, Mikaela Sjöstrand et al. · 2017 · JAMA Cardiology
  31. Diabetic nephropathy: where are we on the journey from pathophysiology to treatment?
    Hugh Gallagher, Rebecca Suckling · 2016 · Diabetes Obesity and Metabolism
  32. Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial
    The EMPA-KIDNEY Collaborative Group, Herrington, William G, Wanner, Christoph, Green, Jennifer B, Hauske, Sibylle J, Judge, Parminder, Mayne, Kaitlin J, Ng, Sarah Y A, Sammons, Emily, Zhu, Doreen et al. · 2022 · Nephrology Dialysis Transplantation
  33. An Age-Calibrated Definition of Chronic Kidney Disease: Rationale and Benefits.
    Pierre Delanaye, Richard J. Glassock, Hans Pottel, Andrew D. Rule · 2016 · Europe PMC (PubMed Central)
  34. Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study
    Kathryn Elizabeth Mansfield, Dorothea Nitsch, Liam L Smeeth, Krishnan Bhaskaran, Laurie A. Tomlinson · 2016 · BMJ Open
  35. Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease
    Stephen Zewinger, Marcus Edi Kleber, Lucia Rohrer, Marlene Lehmann, Sarah Triem, Richard T. Jennings, Ioannis Petrakis, Alexander Dressel, Philipp Moritz Lepper, Hubert Scharnagl et al. · 2017 · European Heart Journal
  36. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
    Mahin Chowdhury, Sarah J Nevitt, Aikaterini Eleftheriadou, Prathap Kanagala, Hani Esa, Daniel James Cuthbertson, Abd A. Tahrani, Uazman Alam · 2021 · BMJ Open Diabetes Research & Care
  37. Interplay of Vitamin D, Erythropoiesis, and the Renin-Angiotensin System
    Domenico Santoro, Daniela Caccamo, Silvia Lucisano, Michele Buemi, Katarı́na Šebeková, Daniel Teta, Luca De Nicola · 2015 · BioMed Research International
  38. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
    Craig Allen Johnston, Jennette Palcic Moreno, John Paul Foreyt · 2014 · Current Atherosclerosis Reports
  39. 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026
    American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, Mandeep, McCoy, Rozalina G., Balapattabi, Kirthikaa, Bannuru, Raveendhara R., Bellini, Natalie J., Bennett, Allison K., Beverly, Elizabeth A., Briggs Early, Kathaleen, ChallaSivaKanaka, Sathyavathi et al. · 2026 · Diabetes Care
  40. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II
    Carlos M. Campos, David V. Klaveren, Vasim Farooq, Charles A. Simonton, A. Pieter Kappetein, Joseph F. Sabik, Ewout Willem Steyerberg, Gregg W. Stone, Patrick W.J.C. Serruys, the EXCEL Trial Investigators · 2015 · European Heart Journal
  41. The impact of hyperfiltration on the diabetic kidney
    Erosha Premaratne, Sudhanshu Kumar Verma, Elif Ilhan Ekinci, G Theverkalam, George Jerums, R. J. MacIsaac · 2014 · Diabetes & Metabolism
  42. New pharmacological strategies for protecting kidney function in type 2 diabetes
    Marcel H.A. Muskiet, David Collins. Wheeler, Hiddo J.L. Heerspink · 2018 · The Lancet Diabetes & Endocrinology
  43. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes
    Oyunchimeg Buyadaa, Dianna J. Magliano, Agus Salim, Digsu N. Koye, Jonathan E. Shaw · 2019 · Diabetes Care
  44. Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
    Kelsey, Michelle D., Nelson, Adam J., Green, Jennifer B., Granger, Christopher B., Peterson, Eric D., McGuire, Darren K., Pagidipati, Neha J. · 2022 · Journal of the American College of Cardiology
  45. HDL Cholesterol Is Not Associated with Lower Mortality in Patients with Kidney Dysfunction
    Zewinger, Stephen, Speer, Thimoteus, Kleber, Marcus E., Scharnagl, Hubert, Woitas, Rainer, Lepper, Philipp M., Pfahler, Karolin, Seiler, Sarah, Heine, Gunnar H., März, Winfried et al. · 2014 · Journal of the American Society of Nephrology
  46. Inhibition of SET Domain–Containing Lysine Methyltransferase 7/9 Ameliorates Renal Fibrosis
    Kensuke Sasaki, Shigehiro Doi, Ayumu Nakashima, Taisuke Irifuku, Kyoko Yamada, Keiko Kokoroishi, Toshinori Ueno, Toshiki Doi, Eisuke Hida, Koji Arihiro et al. · 2015 · Journal of the American Society of Nephrology
  47. Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease
    Jonathan D. Ravid, Mohamed Hassan Kamel, Vipul Chimanlal Chitalia · 2021 · Nature Reviews Nephrology
  48. Renal hyperfiltration defined by high estimated glomerular filtration rate: A risk factor for cardiovascular disease and mortality
    Mehmet Kanbay, Lale A. Ertuğlu, Barış Afşar, Elif Ozdogan, Zeynep S. Kucuksumer, Alberto Ortíz, Adrian Constantin Covic, Masanari Kuwabara, David Z.I. Cherney, Daniël H. van Raalte et al. · 2019 · Diabetes Obesity and Metabolism
  49. Chronic kidney disease
    William Guy Herrington, Parminder K. Judge, Morgan Erika Grams, Christoph Wanner · 2025 · The Lancet
  50. A morphological and functional comparison of proximal tubule cell lines established from human urine and kidney tissue
    Jitske Jansen, Carolien M. S. Schophuizen, Martijn J. G. Wilmer, S.H.M. Lahham, Henricus A. M. Mutsaers, Jack F.M. Wetzels, Ruud A. Bank, Lambertus P. van den Heuvel, Joost G.J. Hoenderop, Rosalinde Masereeuw · 2014 · Experimental Cell Research
  51. Association Between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes
    Jee Hee Yoo, Min Sun Choi, Jiyeon Ahn, Sung Woon Park, Yejin Kim, Kyu Yeon Hur, Sang‐Man Jin, Gyuri Kim, Jae Hyeon Kim · 2020 · Diabetes Technology & Therapeutics
  52. Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial
    Bouchi, Ryotaro, Nakano, Yujiro, Fukuda, Tatsuya, Takeuchi, Takato, Murakami, Masanori, Minami, Isao, Izumiyama, Hajime, Hashimoto, Koshi, Yoshimoto, Takanobu, Ogawa, Yoshihiro · 2017 · Endocrine Journal
  53. Glomerular hyperfiltration is a predictor of adverse cardiovascular outcomes
    Gianpaolo Reboldi, Paolo Verdecchia, Gioia Fiorucci, Lawrence Joseph Beilin, Kazuo Eguchi, Yutaka Imai, Kazuomi Kario, Takayoshi Ohkubo, Sante Donato Pierdomenico, Joseph E. Schwartz et al. · 2017 · Kidney International
  54. Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
    Zhang, Yaofu, Jiang, Li, Wang, Junheng, Wang, Tongxin, Chien, Chieh, Huang, Weijun, Fu, Xiaozhe, Xiao, Yonghua, Fu, Qiang, Wang, Shidong et al. · 2022 · Cardiovascular Diabetology
  55. Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors
    Annalisa Giandalia, Alfio Edoardo Giuffrida, Guido Gembillo, Domenico Cucinotta, Giovanni Squadrito, Domenico Santoro, Giuseppina Tiziana Russo · 2021 · International Journal of Molecular Sciences
  56. Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities
    Prathibha Reddy Gajjala, Maryam Sanati, Joachim Jankowski · 2015 · Frontiers in Immunology
  57. Diabetic nephropathy in Africa: A systematic review
    Jean Jacques Noubiap · 2015 · World Journal of Diabetes
  58. Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies
    Roberto Minutolo, Francis B. Gabbai, Michele Provenzano, Paolo Chiodini, Silvio Borrelli, Carlo Garofalo, Ferdinando Carlo Sasso, Domenico Santoro, Vincenzo Bellizzi, Giuseppe Conte et al. · 2018 · Nephrology Dialysis Transplantation
  59. Cardiovascular risk assessment in low-resource settings
    Pietro Amedeo Modesti, Piergiuseppe Agostoni, Charles O Agyemang, Sanjay Basu, Athanase Bénétos, Francesco Paolo Cappuccio, Antonio Ceriello, Stefano Del Prato, Robert Kalyesubula, Eoin T O'Brien et al. · 2014 · Journal of Hypertension
  60. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
    Morgan Erika Grams, Wei Peter Yang, Casey M. Rebholz, Xue Wang, Anna C. Porter, Lesley A. Inker, Edward J. Horwitz, James Sondheimer, L. Lee Hamm, Jiang He et al. · 2017 · American Journal of Kidney Diseases
  61. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease
    Claire Rimes‐Stigare, Paolo Frumento, Matteo Bottai, Johan Mårtensson, Claes‐Roland Martling, Max Bell · 2015 · Critical Care
  62. Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar
    Chi Pang Wen, Kunihiro Matsushita, Josef Coresh, Kunitoshi Iseki, Muhammad Islam, Ronit Katz, William McClellan, Carmen Alicia Peralta, Haiyan Wang, Dick de Zeeuw et al. · 2014 · Kidney International
  63. Does lifestyle intervention improve health of adults with overweight/obesity and type 2 diabetes? Findings from the Look AHEAD randomized trial
    Wing, Rena R., the Look AHEAD Research Group · 2021 · Obesity
  64. Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications
    Santhosh V. R. Kumar, Murthy N. Darisipudi, Stefanie Steiger, Satish Kumar Devarapu, Maia Tatò, Onkar P. Kukarni, Shrikant R. Mulay, Dana Thomasová, Bastian Popper, Jana Demleitner et al. · 2015 · Journal of the American Society of Nephrology
  65. FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX
    Linlin Ji, Qingzhu Wang, Fengjuan Huang, Tingting An, Feng Guo, Yanyan Zhao, Yang Liu, Yanyan He, Yi Song, Guijun Qin · 2019 · Oxidative Medicine and Cellular Longevity
  66. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
    Yehuda Handelsman, John E. Anderson, George L. Bakris, Christie Mitchell Ballantyne, Deepak L. Bhatt, Zachary T. Bloomgarden, Biykem Bozkurt, Matthew Jay Budoff, Javed Butler, David Z.I. Cherney et al. · 2024 · Metabolism
  67. The Impacts of Albuminuria and Low eGFR on the Risk of Cardiovascular Death, All-Cause Mortality, and Renal Events in Diabetic Patients: Meta-Analysis
    Tadashi Toyama, Kengo Furuichi, Toshiharu Ninomiya, Miho Shimizu, Akinori Hara, Yasunori Iwata, Shuichi Kaneko, Takashi Wada · 2013 · PLoS ONE
  68. Glomerular hyperfiltration as a therapeutic target for CKD
    Mehmet Kanbay, Sidar Çöpür, Çiçek Nur Bakır, Adrian Constantin Covic, Alberto Ortíz, Katherine R. Tuttle · 2024 · Nephrology Dialysis Transplantation
  69. Microalbuminuria: target for renoprotective therapy PRO
    Sara S. Roscioni, Hiddo J.L. Heerspink, Dick de Zeeuw · 2014 · Kidney International
  70. Pleiotropic effects of type 2 diabetes management strategies on renal risk factors
    Marcel H.A. Muskiet, Lennart Tonneijck, Mark M. Smits, Mark H.H. Kramer, Hiddo J.L. Heerspink, Daniël H. van Raalte · 2015 · The Lancet Diabetes & Endocrinology
  71. Widening clinical applications of the SYNTAX Score
    Vasim Farooq, Stuart J. Head, A. Pieter Kappetein, Patrick W.J.C. Serruys · 2013 · Heart
  72. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study
    Adam Shardlow, Natasha J. McIntyre, Simon DS Fraser, Paul J. Roderick, James P. Raftery, Richard Fluck, Christopher William McIntyre, Maarten W. Taal · 2017 · PLoS Medicine
  73. Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale
    Michele Provenzano, Giuseppe Coppolino, Luca De Nicola, Raffaele Serra, Carlo Garofalo, Michele Andreucci, Davide Bolignano · 2019 · Frontiers in Cell and Developmental Biology
  74. Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
    Luis Miguel Ruilope, Bertram Pitt, Stefan D. Anker, Peter R Rossing, Csaba Pal Kovesdy, Roberto Pecoits‐Filho, Pablo E. Pérgola, Amer Joseph, Andrea Z. Lage, Nicole Mentenich et al. · 2022 · Nephrology Dialysis Transplantation
  75. Cohort Profile: The Chronic Kidney Disease Prognosis Consortium
    Kunihiro Matsushita, Shoshana H. Ballew, Brad C. Astor, Paul E. de Jong, R. T. Gansevoort, Brenda R. Hemmelgarn, Andrew S. Levey, Adeera Levin, Chi Wen, Mark Woodward et al. · 2012 · International Journal of Epidemiology
  76. Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes
    Priya Vart, Muthiah Vaduganathan, Niels Jongs, Giuseppe Remuzzi, David Collins. Wheeler, Fan Fan Hou, Finnian R. Mc Causland, Glenn Matthew Chertow, Hiddo J.L. Heerspink · 2022 · Clinical Journal of the American Society of Nephrology
  77. Protein intake and kidney function in the middle-age population: contrast between cross-sectional and longitudinal data
    Massimo Círillo, Cinzia Lombardi, Daniela Chiricone, Natale Gaspare De Santo, Alberto Zanchetti, Giancarlo Bilancio · 2014 · Nephrology Dialysis Transplantation
  78. Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease
    Yanyan Zhao, Ao Shen, Feng Guo, Yi Song, Na Jing, Xiaoxu Ding, Mengxing Pan, Haohao Zhang, Jiao Wang, Lina Wu et al. · 2020 · Frontiers in Endocrinology
  79. The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
    Parminder K. Judge, Katherine R. Tuttle, Natalie Staplin, Sibylle Jenny Hauske, Doreen Zhu, Rebecca J. Sardell, Lisa Cronin, Jennifer B. Green, Nikita Agrawal, Ryoki Arimoto et al. · 2024 · Nephrology Dialysis Transplantation
  80. Periodontal disease, chronic kidney disease and mortality: results from the third national health and nutrition examination survey
    Ana Catherine Ricardo, Ambarish M. Athavale, Jinsong Chen, Hemanth N. Hampole, Daniel B. Garside, Phillip T. Marucha, James Phillip Lash · 2015 · BMC Nephrology
  81. Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals
    Fumitaka Tanaka, Ryosuke Komi, Shinji Makita, Toshiyuki Onoda, Kozo Tanno, Masaki Ohsawa, Kazuyoshi Itai, Kiyomi Sakata, Shinichi Omama, Yuki Yoshida et al. · 2016 · Journal of Hypertension
  82. Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing
    Elena A. Christofides, Niraj B. Desai · 2021 · Journal of Primary Care & Community Health
  83. Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial
    Simke W. Waijer, Di Xie, Silvio E. Inzucchi, Bernard Zinman, Audrey Koitka‐Weber, Michaela Mattheus, Maximillian von Eynatten, Lesley A. Inker, Christoph Wanner, Hiddo J.L. Heerspink · 2020 · Journal of the American Heart Association
  84. Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
    Frank L.J. Visseren, François Mach, Yvo Michiel Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José Manuel Boavida, Davide Capodanno et al. · 2022 · Revista Española de Cardiología
  85. Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications
    Chiara Siracusa, Nicole Carabetta, Maria Benedetta Morano, Marzia Manica, Antonio Strangio, Jolanda Sabatino, Isabella Leo, Alberto Castagna, Eleonora Cianflone, Daniele Torella et al. · 2024 · International Journal of Molecular Sciences
  86. Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease
    Li Fan, Hocine Tighiouart, Andrew S. Levey, Gerald J. Beck, Mark J. Sarnak · 2014 · Kidney International
  87. Association of Kidney Disease Measures With Ischemic Versus Hemorrhagic Strokes
    Bakhtawar Khan Mahmoodi, Hiroshi Yatsuya, Kunihiro Matsushita, Yinying Sang, Rebecca F. Gottesman, Brad C. Astor, Mark Woodward, William T. Longstreth Jr., Bruce M. Psaty, Michael G. Shlipak et al. · 2014 · Stroke
  88. Periodontal treatment in patients with chronic kidney disease: a pilot study
    S. Almeida, Carlos Marcelo Figueredo, Carla Lemos, Rachel Bregman, Ricardo Guimarães Fischer · 2016 · Journal of Periodontal Research
  89. Contribution of Four Comorbid Conditions to Racial/Ethnic Disparities in Mortality Risk
    Jonathan Daw · 2016 · American Journal of Preventive Medicine
  90. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors
    Lucía Cea Soriano, Saga Johansson, Bergur V. Stefánsson, Luis Alberto García Rodríguez · 2015 · Cardiovascular Diabetology
  91. Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK
    Antonio González‐Pérez, María Eugenia Sáez, David Vizcaya, Marcus Lind, Luis García Rodríguez · 2021 · BMJ Open Diabetes Research & Care
  92. Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records
    Jonathan Pearson-Stuttard, Yiling J Cheng, James Bennett, Eszter Panna Vamos, Bin Zhou, Jonathan Valabhji, Amanda J Cross, Majid Ezzati, Edward W. Gregg · 2021 · The Lancet Diabetes & Endocrinology
  93. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes
    Gerasimos S Filippatos, Stefan D. Anker, Bertram Pitt, Peter R Rossing, Amer Joseph, Peter Kolkhof, Marc Lambelet, Robert Lawatscheck, George L. Bakris, Luis Miguel Ruilope et al. · 2022 · JACC Heart Failure
  94. Gut microbiota-derived indole-3-propionic acid alleviates diabetic kidney disease through its mitochondrial protective effect via reducing ubiquitination mediated-degradation of SIRT1
    Yan Zeng, Man Guo, Qi Wu, Xiaozhen Tan, Chunxia Jiang, Fang‐Yuan Teng, Jiao Chen, Fanjie Zhang, Xiumei Ma, Xinyue Li et al. · 2024 · Journal of Advanced Research
  95. Microvascular endothelial dysfunction is associated with albuminuria
    Remy J.H. Martens, Alfons J.H.M. Houben, Jeroen Peter Kooman, Tos T. J. M. Berendschot, Pieter C. Dagnelie, Carla Kallen, Abraham A. Kroon, Karel M.L. Leunissen, Frank M. VAN DER SANDE, Nicolaas C. Schaper et al. · 2018 · Journal of Hypertension
  96. Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project
    Dietrich Rothenbacher, Martin Rehm, Licia Iacoviello, Simona Costanzo, Hugh Tunstall‐Pedoe, J. J. F. Belch, Stefan Söderberg, Johan Hultdin, Veikko V Salomaa, Pekka Jousilahti et al. · 2020 · BMC Medicine
  97. Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus
    Mazen Alsahli, John E. Gerich · 2014 · Mayo Clinic Proceedings
  98. Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)
    Daniel E. Weiner, Sarah A. Gaussoin, John W. Nord, Alexander P. Auchus, Gordon J. Chelune, Michel Chonchol, Laura H. Coker, William E. Haley, Anthony A. Killeen, Paul L. Kimmel et al. · 2017 · American Journal of Kidney Diseases
  99. Associations Between Estimated Glomerular Filtration Rate and Stroke Outcomes in Diabetic Versus Nondiabetic Patients
    Yang Luo, Xianwei Wang, Kunihiro Matsushita, Chunxue Wang, Xingquan Zhao, Bo Hu, Liping Liu, Hao Li, Gaifen Liu, Qian Jia et al. · 2014 · Stroke
  100. Genetic and epigenetic factors influencing chronic kidney disease
    Laura Jane Smyth, Seamus Duffy, Alexander Peter Maxwell, Amy Jayne McKnight · 2014 · American Journal of Physiology-Renal Physiology